Director of Rheumatology, Medical Affairs Therapeutic Area Stronghold-0222140513
Description
Janssen Biotech, Inc. is recruiting for a Director of Rheumatology, Medical Affairs Therapeutic Area Stronghold to be located in Horsham, PA.
For more than 30 years, Janssen Biotech, Inc. (JBI) has delivered on the promise of new treatments and ways to improve the health of individuals with serious disease. Built upon a rich legacy of innovative first, Janssen Biotech, Inc. pursues innovative solutions in the therapeutic areas of immunology, oncology, urology and nephrology. With the same unwavering passion for new challenges, we dedicate ourselves to delivering solutions for these disease states where unmet needs continue to exist. Rooted in rich scientific collaborations and community-based relationships, we have access to some of the top minds in science today, allowing us to advance the treatment of patients through our innovative medicines. Our discoveries lead us not only to new treatments, but also to new ways to empower patients and expand their access to quality care.
Thriving on a diverse company culture, celebrating the uniqueness of our employees and committed to inclusion. Proud to be an equal opportunity employer.
The Medical Affairs Therapeutic Area Stronghold (MATAS) team is responsible for developing, coordinating and executing the Therapeutic Area strategic plan for Medical Affairs. This position resides in the MATAS and is primarily responsible for designing and executing registries, Phase IIIb/IV trials and other post-marketing requirements within the areas of JBI’s current or emerging indications. This position supports research in Immunology in late Phase development. The MATAS team includes Medical Affairs Physicians, Research Scientists, and Operations members. The Director Clinical Research, Rheumatology position will be part of the MATAS team and will work closely with US and Medical Affairs team members on Rheumatology research as well as with other key partners of Medical Affairs supporting Immunology and Oncology within JBI.
More specifically, the Director will be responsible for the development and execution of Medical Affairs sponsored and supported clinical programs for company products in the Rheumatology therapeutic area. This will include study design, protocol development, execution, and supervision of clinical studies of all types: Phase IIIb/IV, registries and investigator initiated studies supported by Medical Affairs. In addition, the Director will manage people or groups within MATAS either with direct reports or through a matrix structure.
The successful applicant will be responsible for medical monitoring/reporting and activities to support communication with company safety officers. Trial conduct and tracking will require close interaction with members of Global Clinical Operations directly responsible for each trial supported by the operating company. A strong working relationship with the Clinical Research and Development organization as well as Regulatory Affairs and Medical Communication will be essential. The M.D./D.O. and/or Ph.D. within MATAS should be perceived as a peer by clinical research leaders in all disease areas under research as direct involvement in the interpretation and data display across therapeutic areas is anticipated. This applicant will also work with the strategic lead in Rheumatology to support other appropriate efforts.
Essential Functions include: Direct involvement in trial design of Phase IIIb/IV research trials targeting rheumatologic diseases; work closely with the clinical project scientist group and GCO to manage trial logistics; work closely with the project management representative(s) to track trial status; be prepared to quickly identify trial conduct and logistical problems and provide solutions to rectify the issues as appropriate; partner closely with different global medical affairs teams, the GCO Clinical Project-Liaisons, as well as other individuals within medical affairs and other functional areas within JNJ as necessary to facilitate research expanding the knowledge of JBI products; work with and communicate to the steering committees of trials; write as well as provide editorial comments for phase IIIb/IV clinical study reports and manuscripts.
Qualifications
MD/DO and/or PhD is strongly preferred. A minimum of 5 years of clinical and managerial experience in pharmaceutical trial design and conduct (Phases II-IV) within the pharmaceutical industry or CRO is preferred. Experience in clinical studies in Rheumatology, Dermatology, Gastroenterology or Oncology is preferred but not required. Experience with production of trial analytical reports and interacting with global regulatory authorities is strongly preferred. Excellent interpersonal and communication skills are required. Demonstrated ability to work in a matrix environment with interaction with cross-functional teams is preferred. Up to 20% annual travel (domestic and international) is required for this position.
BE VITAL in your career, Be seen for the talent you bring to your work. Explore opportunities within the Johnson & Johnson Family of Companies.
J2W: LI NA
Primary Location:North America-United States-Pennsylvania-Horsham
Organization: Janssen Scientific Affairs, LLC (6120)
Job Function: Medical Affairs
Certain sites within the Johnson & Johnson Family of Companies participate in E-Verify as appropriate in accordance with Company guidelines and federal or state law. To learn more about the government sponsored program and to see a list of the sites that are currently enrolled, please click here.
Johnson and Johnson Family of Companies are equal opportunity employers, and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, protected veteran status, or disability status, or any other characteristic protected by law.
EEO is the Law
EEO is the Law GINA Supplement